Related references
Note: Only part of the references are listed.Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial
Marco Valgimigli et al.
CIRCULATION (2012)
Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents A Prospective Cohort Study
Lorenz Raeber et al.
CIRCULATION (2012)
Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention The Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV)
Lisette Okkels Jensen et al.
CIRCULATION (2012)
Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent Thrombosis
Ehrin J. Armstrong et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
Examination of the In Vivo Mechanisms of Late Drug-Eluting Stent Thrombosis Findings From Optical Coherence Tomography and Intravascular Ultrasound Imaging
Giulio Guagliumi et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients The TWENTE Trial
Clemens von Birgelen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Two-Year Safety and Effectiveness of Sirolimus-Eluting Stents (from a Prospective Registry)
Bimmer E. Claessen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction
George D. Dangas et al.
CIRCULATION (2011)
Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial
Lorenz Raeber et al.
CIRCULATION (2011)
Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention The GRAVITAS Randomized Trial
Matthew J. Price et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI
Guido Parodi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention A Collaborative Meta-Analysis of Individual Participant Data
Somjot S. Brar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention The EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) Randomized Trial
Kyung Woo Park et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Impact of the Everolimus-Eluting Stent on Stent Thrombosis A Meta-Analysis of 13 Randomized Trials
Usman Baber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents
Gregg W. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease 3-Year Outcomes From a Randomized Clinical Trial
Robert A. Byrne et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice
Pieter C. Smits et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Long-Term Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents for Coronary Revascularization
Lorenz Raeber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Pathology of Neoatherosclerosis in Human Coronary Implants Bare-Metal and Drug-Eluting Stents
Gaku Nakazawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents
Gaku Nakazawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial
Sigmund Silber et al.
LANCET (2011)
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial
Giulio G. Stefanini et al.
LANCET (2011)
Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents Observations From the Registry of Stent Thrombosis for Review and Reevaluation (RESTART)
Takeshi Kimura et al.
CIRCULATION (2010)
Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
William Wijns et al.
EUROPEAN HEART JOURNAL (2010)
Incidence and Predictors of Very Late (>= 4 Years) Major Cardiac Adverse Events in the DESIRE (Drug-Eluting Stents in the Real World)-Late Registry
J. Ribamar Costa et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial
Martin B. Leon et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions 12-Month Outcomes From the ENDEAVOR IV Trial
Martin B. Leon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
Elvin Kedhi et al.
LANCET (2010)
Comparison of ticagrelor with clopidogrel in patients with planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
Christopher P. Cannon et al.
LANCET (2010)
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
Klaus Rasmussen et al.
LANCET (2010)
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents.
Seung-Jung Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
Patrick W. Serruys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
Takeshi Kimura et al.
CIRCULATION (2009)
Drug-Eluting Stent Thrombosis in Routine Clinical Practice: Two-Year Outcomes and Predictors From the TAXUS ARRIVE Registries
J. M. Lasala et al.
Circulation-Cardiovascular Interventions (2009)
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
Stefanie Schulz et al.
EUROPEAN HEART JOURNAL (2009)
Predictors of Coronary Stent Thrombosis The Dutch Stent Thrombosis Registry
Jochem W. van Werkum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Correlates of late and very late thrombosis of drug eluting stents
Gregory J. Mishkel et al.
AMERICAN HEART JOURNAL (2008)
Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period
Tina L. Pinto Slottow et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients - An autopsy study
Gaku Nakazawa et al.
CIRCULATION (2008)
Drug-eluting stent thrombosis -: Results from the Multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos)
Jos M. de la Torre-Hernandez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The Vulnerable stent - Why so dreadful?
Fernando Alfonso
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Endothelial cell recovery between comparator polymer-based drug-eluting stents
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
Spencer B. King et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice -: 4-year results from a large 2-institutional cohort study
Peter Wenaweser et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
Stephen D. Wiviott et al.
LANCET (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
Flavio Airoldi et al.
CIRCULATION (2007)
Late and very late thrombosis of drug-eluting stents - Evolving concepts and perspectives
Ronen Jaffe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation
Stephane Cook et al.
CIRCULATION (2007)
Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization
Aloke V. Finn et al.
CIRCULATION (2007)
Thrombosis in coronary drug-eluting stents - Report from the meeting of the circulatory system medical devices advisory panel of the food and drug administration center for devices and radiologic health, December 7-8, 2006
Warren K. Laskey et al.
CIRCULATION (2007)
Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent - A TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years
Stephen G. Ellis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
Adnan Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Stent thrombosis in randomized clinical trials of drug-eluting stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents
Christian Spaulding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Drug-eluting stent and coronary thrombosis -: Biological mechanisms and clinical implications
Thomas F. Luescher et al.
CIRCULATION (2007)
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study
Joost Daemen et al.
LANCET (2007)
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
Eric L. Eisenstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents - An observational study of drug-eluting versus bare-metal stents
Matthias Pfisterer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials
Anthony A. Bavry et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up
Duk-Woo Park et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Safety of coronary Sirolimus-Eluting Stents in daily clinical practice - One-year follow-up of the e-cypher registry
P Urban et al.
CIRCULATION (2006)
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents
PK Kuchulakanti et al.
CIRCULATION (2006)
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention - The role of dual drug resistance
EI Lev et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Aspirin resistance and atherothrombotic disease
PJ Mason et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Late angiographic stent thrombosis (LAST) events with drug-eluting stents
ATL Ong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Drug-eluting stent thrombosis -: Results from a pooled analysis including 10 randomized studies
R Moreno et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis -: A randomized controlled trial
A Kastrati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious?
R Virmani et al.
CIRCULATION (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
GW Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
EP McFadden et al.
LANCET (2004)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
M Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
